RT is a feasible and effective treatment modality in cancer patients aged ≥ 80 years, particularly in those with good performance status. These findings advocate for individualized treatment decisions based on functional status rather than chronological age and emphasize the need for more age-inclusive clinical research.
Thakur et al. (Thu,) studied this question.